Capital World Investors 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 6:19 pm Sale | 2024-02-07 | 13G | Fate Therapeutics, Inc. FATE | Capital World Investors | 0 0.000% | -5,591,517 (Position Closed) | Filing |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Fate Therapeutics, Inc. FATE | Capital World Investors | 5,591,517 5.800% | 5,591,517 (New Position) | Filing |